$NVST

Envista Holdings Corp

No enriched coverage for $NVST in the last 7 days.

No SEC Form 4 filings for $NVST in the last 30 days.

Low

Vanguard shows 8.57M-share stake in Envista (NVST) in Schedule 13G

Vanguard Capital Management has disclosed an 8,574,557-share stake in Envista Holdings Corp (NVST), representing 5.23% of the company's common stock as of March 31, 2026. This Schedule 13G filing indicates Vanguard holds sole dispositive power over all these shares and sole voting power over 1,255,976 shares. The investment is described as being in the ordinary course of business and not for the purpose of influencing control of the issuer.

Envista, Baxter, Artivion, Dentsply Sirona, and Cigna Stocks Trade Down, What You Need To Know

Several healthcare and dental companies, including Envista, Baxter, Artivion, Dentsply Sirona, and Cigna, saw their stock prices fall after a February jobs report indicated an unexpected contraction in employment and significant job losses in the healthcare sector. This data has raised concerns among investors about a potential economic slowdown and decreased healthcare spending. Dentsply Sirona, in particular, experienced a 4.1% drop despite a recent 13.4% gain a week prior due to a revenue beat, though its full-year guidance was disappointing.

Dental Equipment & Technology Q3 Earnings: Envista (NYSE:NVST) Simply the Best

Envista Holdings (NYSE:NVST) delivered the strongest Q3 performance among tracked dental equipment and technology stocks, beating analyst revenue estimates significantly and achieving the fastest revenue growth. Henry Schein (NYSE:HSIC) and Align Technology (NYSE:ALGN) also reported strong quarters, with their stocks rising after earnings. Dentsply Sirona (NYSE:XRAY), however, had the weakest performance with declining revenues and missed EPS guidance.